Tag Archives: Pfizer

Japan is looking into the possibility of mixing shots of AstraZeneca Plc’s COVID-19 vaccine with those developed by other drugmakers in a bid to speed up its vaccine rollout, the minister in charge of vaccinations said on Sunday. Japan, which has previously relied on the Pfizer Inc/BioNTech SE and Moderna …

The US Food and Drug Administration on Monday fully approved Pfizer’s COVID-19 vaccine, a move expected to trigger a new wave of vaccine mandates as the delta variant batters the country. “The FDA’s approval of this vaccine is a milestone as we continue to battle the COVID-19 pandemic,” acting FDA …

With governments around the world debating whether to authorize COVID-19 vaccine booster doses, Moderna Inc. co-founder Noubar Afeyan envisions a time when the shot could become routine. “Public health officials are going to have to decide if everybody should get a booster shot, he said in an interview on “The …

A new study is raising concerns about effectiveness of mRNA vaccines like Pfizer, which has been effective against the fast spreading Delta variant of COVID-19 only 42 percent in US. The data was from the month of July, when Delta was the dominant variant of the coronavirus, according to the …

Facebook has removed hundreds of accounts linked to a disinformation network operating out of Russia that sought to smear COVID-19 vaccines made by Pfizer and AstraZeneca Facebook said Tuesday that it has removed hundreds of accounts linked to a mysterious advertising agency operating out of Russia that sought to pay …

The Ministry of Health announced today, Sunday,  the arrival of the largest batch of the Pfizer and Sinopharm vaccines, while indicating that the shipment will be distributed to all vaccination outlets in Baghdad and all governorates, including the Kurdistan region . The ministry said in a statement received by  AlghadeerTv, …

However, a booster dose will be necessary prior to the winter season as antibody levels are likely to wane, Moderna said. Moderna said on Thursday its Covid-19 shot was about 93 percent effective through six months after the second dose, showing hardly any change from the 94 percent efficacy reported …

The largest clinical trial investigating the best gap between first and second COVID-19 vaccine doses for pregnant women has been launched in the UK. Following 130,000 pregnant women being vaccinated in the US and no safety concerns being raised, the Pfizer/BioNTech and Moderna vaccines were recommended by the independent experts …

Australia’s New South Wales reported one of the country’s youngest deaths from COVID-19 on Wednesday, as daily infections lingered near a 16-month high despite the lockdown of five million people in state capital Sydney entering its sixth week. The unnamed man in his 20s, who had no underlying health issues …

Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccine in the latest European Union supply contracts, The Financial Times reported on Sunday. The new price for the Pfizer shot was 19.50 euros ($23.15) against 15.50 euros previously, the newspaper said citing the portions of the contracts …

The effectiveness of the Pfizer-BioNTech COVID-19 vaccine dropped from 96 percent to 84 percent over six months, a new study funded by the companies showed. The study, published on Wednesday, showed that while the efficacy level of the Pfizer vaccine reached a peak of 96.2 percent within the first two …

A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed. The study involved 499 medical workers – 100 receiving mixed doses, 200 taking two doses of the Pfizer/BioNTech shot, and …

The EU’s medicines regulator has given its backing for Moderna’s Covid-19 vaccine to be administered to minors aged between 12 and 17, citing positive results in trials involving 3,732 participants. In a statement on Friday, the European Medicines Agency (EMA) gave its recommendation for the Spikevax Covid-19 shot to be …

A longer gap between doses of Pfizer’s COVID-19 vaccine leads to higher overall antibody levels than a shorter gap, a British study found on Friday, but there is a sharp drop in antibody levels after the first dose. The study might help inform vaccination strategies against the Delta variant, which …

Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage. Researchers are trying to determine just what level of COVID-19 antibodies a vaccine must produce to provide protection …

COVID-19 vaccine maker Pfizer Inc will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday. The meeting comes days after the drugmaker and its partner BioNTech SE …

Pfizer and BioNTech say that a third COVID-19 booster dose given about six months after the second shot improves vaccine efficacy against new coronavirus variants and that this is backed by initial data from their study on booster shots. While the COVID-19 vaccine remains 95% effective in preventing serious cases, …

Newly-published research from France’s Pasteur Institute suggests that people are mostly protected from the Delta variant of coronavirus after two doses of a COVID-19 vaccine. The study, published in Nature journal on Thursday, tested the effects of exposure to the hyper-infectious strain first identified in India on 59 vaccinated people …

Australian officials extended lockdown and social distancing measures to more of the country on Wednesday, with four major cities already under a hard lockdown in a race to contain an outbreak of the highly contagious Delta coronavirus variant. Summary | NSW total cases in latest outbreak top 170 South Australia logs …

Immune cells are still organizing to fight the coronavirus months after inoculation, scientists reported. The vaccines made by Pfizer-BioNTech and Moderna set off a persistent immune reaction in the body that may protect against the coronavirus for years, scientists reported on Monday. The findings add to growing evidence that most …